Almac Discovery Ltd.-Product Pipeline Review-2015

Almac Discovery Ltd.-Product Pipeline Review-2015

  • Products Id :- GMDHC06834CDB
  • |
  • Pages: 32
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Almac Discovery Ltd.-Product Pipeline Review-2015


Global Markets Direct's, 'Almac Discovery Ltd.-Product Pipeline Review-2015', provides an overview of the Almac Discovery Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Almac Discovery Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


The report provides brief overview of Almac Discovery Ltd. including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Almac Discovery Ltd.'s human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Almac Discovery Ltd.'s pipeline products

Reasons To Buy

Evaluate Almac Discovery Ltd.'s strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Almac Discovery Ltd. in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Almac Discovery Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Almac Discovery Ltd. and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Almac Discovery Ltd.

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of Almac Discovery Ltd. and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Almac Discovery Ltd. Snapshot 5

Almac Discovery Ltd. Overview 5

Key Information 5

Key Facts 5

Almac Discovery Ltd.-Research and Development Overview 6

Key Therapeutic Areas 6

Almac Discovery Ltd.-Pipeline Review 9

Pipeline Products by Stage of Development 9

Pipeline Products-Monotherapy 10

Almac Discovery Ltd.-Pipeline Products Glance 11

Almac Discovery Ltd.-Clinical Stage Pipeline Products 11

Phase I Products/Combination Treatment Modalities 11

Almac Discovery Ltd.-Early Stage Pipeline Products 12

Preclinical Products/Combination Treatment Modalities 12

Discovery Products/Combination Treatment Modalities 13

Almac Discovery Ltd.-Unknown Stage Pipeline Products 14

Unknown Products/Combination Treatment Modalities 14

Almac Discovery Ltd.-Drug Profiles 15

ALM-201 15

Product Description 15

Mechanism of Action 15

R&D Progress 15

AD-01 16

Product Description 16

Mechanism of Action 16

R&D Progress 16

ADC-0008830 17

Product Description 17

Mechanism of Action 17

R&D Progress 17

ALM-301 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

Small Molecules to Inhibit Akt1/2 for Cancer 19

Product Description 19

Mechanism of Action 19

R&D Progress 19

Small Molecule to Inhibit WEE-1 for Cancer 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

Small Molecules to Modulate Deubiquitinating Enzymes for Cancers 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

Small Molecules to Target DNA for Oncology 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

Small Molecules for Cancer 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

Almac Discovery Ltd.-Pipeline Analysis 24

Almac Discovery Ltd.-Pipeline Products by Target 24

Almac Discovery Ltd.-Pipeline Products by Route of Administration 25

Almac Discovery Ltd.-Pipeline Products by Molecule Type 26

Almac Discovery Ltd.-Pipeline Products by Mechanism of Action 27

Almac Discovery Ltd.-Recent Pipeline Updates 28

Almac Discovery Ltd.-Dormant Projects 29

Almac Discovery Ltd.-Locations And Subsidiaries 30

Head Office 30

Appendix 31

Methodology 31

Coverage 31

Secondary Research 31

Primary Research 31

Expert Panel Validation 31

Contact Us 31

Disclaimer 32

List of Tables

Almac Discovery Ltd., Key Information 5

Almac Discovery Ltd., Key Facts 5

Almac Discovery Ltd.-Pipeline by Indication, 2015 8

Almac Discovery Ltd.-Pipeline by Stage of Development, 2015 9

Almac Discovery Ltd.-Monotherapy Products in Pipeline, 2015 10

Almac Discovery Ltd.-Phase I, 2015 11

Almac Discovery Ltd.-Preclinical, 2015 12

Almac Discovery Ltd.-Discovery, 2015 13

Almac Discovery Ltd.-Unknown, 2015 14

Almac Discovery Ltd.-Pipeline by Target, 2015 24

Almac Discovery Ltd.-Pipeline by Route of Administration, 2015 25

Almac Discovery Ltd.-Pipeline by Molecule Type, 2015 26

Almac Discovery Ltd.-Pipeline Products by Mechanism of Action, 2015 27

Almac Discovery Ltd.-Recent Pipeline Updates, 2015 28

Almac Discovery Ltd.-Dormant Developmental Projects,2015 29

List of Figures

Almac Discovery Ltd.-Pipeline by Top 10 Indication, 2015 7

Almac Discovery Ltd.-Pipeline by Stage of Development, 2015 9

Almac Discovery Ltd.-Monotherapy Products in Pipeline, 2015 10

Almac Discovery Ltd.-Pipeline by Top 10 Target, 2015 24

Almac Discovery Ltd.-Pipeline by Top 10 Route of Administration, 2015 25

Almac Discovery Ltd.-Pipeline by Top 10 Molecule Type, 2015 26

Almac Discovery Ltd.-Pipeline Products by Top 10 Mechanism of Action, 2015 27

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@]

Current R&D Portfolio of Almac Discovery Ltd.; Almac Discovery Ltd. - Key Therapeutics; Almac Discovery Ltd. - Pipeline Overview and Promising Molecules; Almac Discovery Ltd. - News; Almac Discovery Ltd. - Latest Updates; Almac Discovery Ltd. - Pipeline; Almac Discovery Ltd. - Discontinued/Dormant Projects

select a license

Single User License
USD 1500 INR 101175
Site License
USD 3000 INR 202350
Corporate User License
USD 4500 INR 303525



Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@]